Adalimumab for the treatment of fistulas in patients with Crohn’s disease

OBJECTIVE: To evaluate the efficacy of adalimumab in the healing of draining fistulas in patients with active Crohn’s disease (CD). DESIGN: A phase III, multicentre, randomised, double-blind, placebo controlled study with an open-label extension was conducted in 92 sites. PATIENTS: A subgroup of adu...

Descripción completa

Detalles Bibliográficos
Autores principales: Colombel, J-F, Schwartz, D A, Sandborn, W J, Kamm, M A, D’Haens, G, Rutgeerts, P, Enns, R, Panaccione, R, Schreiber, S, Li, J, Kent, J D, Lomax, K G, Pollack, P F
Formato: Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2009
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689393/
https://www.ncbi.nlm.nih.gov/pubmed/19201775
http://dx.doi.org/10.1136/gut.2008.159251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689393/
https://www.ncbi.nlm.nih.gov/pubmed/19201775
http://dx.doi.org/10.1136/gut.2008.159251

Ejemplares similares